Moderna

Pursuing Pfizer, J&J and Moderna since mid-2020 for earliest possible vaccine imports: Govt

5:52 pm May 27, 2021

New Delhi: Facing accusations of delay in placing orders for vaccines, the government on Thursday defended its vaccine procurement policy saying it has been pursuing Pfizer, J&J and Moderna since mid-2020 for the earliest possible imports, and has even waived local trials for well-established foreign vaccine makers. ”Buying vaccines internationally is not similar to buying ‘off-the-shelf items,” the […]

Read More

2 Oxford/AstraZeneca vaccine doses 85-90 per cent effective, real-world study finds

3:26 pm May 21, 2021

London: Two doses of the Oxford/AstraZeneca vaccine have shown to prevent around 85 to 90 per cent of symptomatic COVID-19 infections, the first real-world data from Public Health England (PHE) has found. The method used for the ‘COVID-19 Vaccine Surveillance Report’ by PHE for analysing the approximate number of deaths and hospitalisations prevented by the vaccine programme was able to take into […]

Read More

Biden to boost world vaccine sharing commitment to 80M doses

11:23 pm May 17, 2021

Washington: President Joe Biden will announce Monday that the US will share an additional 20 million doses of COVID-19 vaccines with the world in the coming six weeks, the White House said. The doses would come from existing US production of Pfizer, Moderna or Johnson & Johnson vaccine stocks, according White House press secretary Jen Psaki, who said more details would be released in the coming days. It comes […]

Read More

Biden move to share vaccine designed to spread US influence

11:30 pm May 8, 2021

Washington: It won’t speed the manufacture of vaccines. It enraged the developers who delivered lifesaving doses in record time. But President Joe Biden’s decision to support waiving intellectual property rights for coronavirus shots had a broader purpose: to broadcast his administration’s commitment to global leadership. More than a month of internal debate led up to […]

Read More
US recommends ‘pause’ for J&J vaccine over clot reports

US recommends ‘pause’ for J&J vaccine over clot reports

10:24 pm April 13, 2021

WASHINGTON: The U.S. on Tuesday recommended a “pause” in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, a development that could jeopardize the rollout of vaccines around the world. The Centers for Disease Control and Prevention and the Food and Drug Administration announced that they […]

Read More